Recently, a multivariate analysis of EpCam expression in CRC by immunohistochemistry has demonstrated that its downregulation represents an independent prognostic factor associated with poor disease-specific survival [38] and is associated with an increase in the migratory capacity of the tumor cells [97,98]. Here, EPCAM is linked to neoplasm.